A6X.F AXICHEM AB A

Basic Materials Chemicals Frankfurt Exchange
0.1160 EUR
Close of Nov 10, 2026
0.0698 0.2940
Market cap
EUR 7.86M
P/E
-
P/B
1.56x
ROE
-25.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is A6X.F undervalued?

Graham number

The Graham number of AXICHEM AB A cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AXICHEM AB A fundamental analysis

No fundamental analysis for AXICHEM AB A yet.

AXICHEM AB A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AXICHEM AB A

aXichem AB (publ), a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved heal…

Full company profile